Skip to main content

Table 4 Effectiveness of ViPS vaccine against clinical typhoid in 2016–2017 after Nepal earthquake 2015

From: A description of a pre-emptive typhoid Vi capsular polysaccharide vaccination campaign after the 2015 earthquake in Nepal and vaccine effectiveness evaluation

 

Cases/controls (n)

Crude VE (95% CI)

Adjusted VE (95% CI)

Overall VE

102/164

22% (−82 to 66)

52% (−46 to 84)

Stratified analyses

 Sex

  Male

70/98

2% (−171 to 65)

41% (−158 to 86)

  Female

32/66

52% (−142 to 90)

54% (−169 to 92)

 Age groups

   < 5 years

37/94

26% (−186 to 81)

87% (−25 to 99)

   ≥ 5 years

65/70

21% (−141 to 74)

−10% (−372 to 75)

  1. ViPS, Vi Polysaccharide vaccine; VE, vaccine effectiveness